{"id":"W2191511762","doi":"10.1158/1078-0432.ccr-15-1349","title":"Gemtuzumab Ozogamicin Reduces Relapse Risk in <i>FLT3</i> /ITD Acute Myeloid Leukemia: A Report from the Children's Oncology Group","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; Alex's Lemonade Stand Foundation for Childhood Cancer","keywords":"Gemtuzumab ozogamicin; Medicine; Oncology; Myeloid leukemia; Internal medicine; Leukemia; Calicheamicin; Biology; CD33","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.02249384,0.0004515367,0.001458093,0.0004199049,0.0003705902,0.0001174793,0.001642569,0.001087788,0.0004095223],"category_scores_gemma":[0.01637092,0.0003086986,0.0004160526,0.002110972,0.002540483,0.000258936,0.001558161,0.01072724,0.0006736183],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.007870656,"about_ca_system_score_gemma":0.01415446,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.04596873,"about_ca_topic_score_gemma":0.004970944,"domain_scores_codex":[0.9868598,0.00436434,0.002133689,0.001897868,0.002857037,0.001887251],"domain_scores_gemma":[0.9876007,0.006924318,0.0004708467,0.002439753,0.001191659,0.001372739],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.01431081,0.0008228612,0.4246454,0.0000227269,0.001025258,0.007597663,0.0009601414,0.00002619082,0.0009975564,0.00009362815,0.4324895,0.1170083],"study_design_scores_gemma":[0.02921784,0.007206062,0.687429,0.0005127387,0.0006383045,0.001201242,0.002131926,0.0007591919,0.001576212,0.003990876,0.2644842,0.000852443],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9606851,0.004649058,0.00002474996,0.02457094,0.0008617919,0.002351873,0.000179623,0.0001265031,0.00655034],"genre_scores_gemma":[0.9688747,0.01743308,0.001079485,0.001882799,0.004558271,0.0007559917,0.000356339,0.0001633121,0.004896029],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2627836,"threshold_uncertainty_score":0.9999365,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1479212835732433,"score_gpt":0.4890948956744304,"score_spread":0.3411736121011871,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}